Showing results (161-170 of 257) with videos related to
Sort By:
Pageof 26
International Journal of Cancer|May 4, 1995
The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 monthsA J Remmink, J M Walboomers, T J Helmerhorst, et al.Clinical Chemistry|December 1, 1987
Time-resolved immunofluorometric assay for the ovarian carcinoma-associated antigenic determinant CA 125 in serumO C Boerman, C M Thomas, M F Segers, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 9, 1998
'Epitope fingerprinting' using overlapping 20-mer peptides of the MUC1 tandem repeat sequenceD J Schol, M F Meulenbroek, F G Snijdewint, et al.Gynecologic Oncology|May 8, 1998
Estimation of probability of malignancy using a logistic model combining physical examination, ultrasound, serum CA 125, and serum CA 72-4 in postmenopausal women with a pelvic mass: an international multicenter studyE M Schutter, C Sohn, P Kristen, et al.Cancer|August 15, 1994
Diagnostic value of pelvic examination, ultrasound, and serum CA 125 in postmenopausal women with a pelvic mass. An international multicenter studyE M Schutter, P Kenemans, C Sohn, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1993
Characterization of cytotoxic T lymphocyte epitopes of a self-protein, p53, and a non-self-protein, influenza matrix: relationship between major histocompatibility complex peptide binding affinity and immune responsiveness to peptidesH W Nijman, J G Houbiers, S H van der Burg, et al.Neurology|January 21, 2009
Plasma Abeta, homocysteine, and cognition: the Vitamin Intervention for Stroke Prevention (VISP) trialA Viswanathan, S Raj, S M Greenberg, et al.Gynecologic Oncology|December 1, 1994
Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancerJ M Bonfrer, K N Gaarenstroom, G G Kenter, et al.Nuclear Medicine Communications|December 1, 1992
Tumour detection and localization using 99Tcm-labelled OV-TL 3 Fab' in patients suspected of ovarian cancerJ G Tibben, L F Massuger, R A Claessens, et al.European Journal of Clinical Investigation|August 23, 2002
Effects of hormone replacement therapy on blood plateletsA Thijs, W M van Baal, M J van der Mooren, et al.Pageof 26